Loading clinical trials...
Loading clinical trials...
This trial is conducted in the United States of America (USA). This trial compares the changes in HbA1c after 26 weeks of repaglinide and metformin fixed dose combination tablet given as twice daily v...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novo Nordisk A/S
NCT05398783 · Metabolic Disorders, Cancer, and more
NCT07224321 · Type 1 Diabetes Mellitus
NCT01399385 · Healthy, Obesity, and more
NCT07395050 · Stage 3 Type 1 Diabetes
NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus
Novo Nordisk Investigational Site
Vestavia Hills, Alabama
Novo Nordisk Investigational Site
Glendale, Arizona
Novo Nordisk Investigational Site
Mesa, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions